Academic Journals Database
Disseminating quality controlled scientific knowledge

Cancer Management and Research

ISSN: 1179--1322
Publisher: Dove Press


ADD TO MY LIST
 
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)

Author(s): Rossi L | Vakiarou F | Zoratto F | Bianchi L | Papa A | Basso E | Verrico M | Lo Russo G | Evangelista S | Rinaldi G | Perrone-Congedi F | Spinelli GP | Stati V | Caruso D | Prete A | Tomao S
Volume: 2013
Issue: default
Year: 2013
The claudin family of proteins in human malignancy: a clinical perspective

Author(s): Ding L | Lu Z | Lu Q | Chen YH
Volume: 2013
Issue: default
Year: 2013
Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety

Author(s): Welker MW | Trojan J
Volume: 2013
Issue: default
Year: 2013
Benefit risk assessment and update on the use of docetaxel in the management of breast cancer

Author(s): Alken S | Kelly CM
Volume: 2013
Issue: default
Year: 2013
The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival

Author(s): Tantraworasin A | Saeteng S | Lertprasertsuke N | Arayawudhikul N | Kasemsarn C | Patumanond J
Volume: 2013
Issue: default
Year: 2013
Focal low-dose rate brachytherapy for the treatment of prostate cancer

Author(s): Tong WY | Cohen G | Yamada Y
Volume: 2013
Issue: default
Year: 2013
Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit

Author(s): Giles MH | Coventry BJ
Volume: 2013
Issue: default
Year: 2013
Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy

Author(s): Merlini L | Cartenì G | Iacobelli S | Stelitano C | Airoldi M | Balcke P | Keil F | Haslbauer F | Belton L | Pujol B
Volume: 2013
Issue: default
Year: 2013
Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma

Author(s): Macha MA | Batra SK | Ganti AK
Volume: 2013
Issue: default
Year: 2013
The role of epithelial–mesenchymal transition programming in invasion and metastasis: a clinical perspective

Author(s): Creighton CJ | Gibbons DL | Kurie JM
Volume: 2013
Issue: default
Year: 2013
Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management

Author(s): Mason JW | Moon TE
Volume: 2013
Issue: default
Year: 2013
Cancer-associated thrombosis: clinical presentation and survival

Author(s): Amer MH
Volume: 2013
Issue: default
Year: 2013
The association of race with timeliness of care and survival among Veterans Affairs health care system patients with late-stage non-small cell lung cancer

Author(s): Zullig LL | Carpenter WR | Provenzale DT | Weinberger M | Reeve BB | Williams CD | Jackson GL
Volume: 2013
Issue: default
Year: 2013
New and emerging combination therapies for esophageal cancer

Author(s): Wiedmann MW | Mössner J
Volume: 2013
Issue: default
Year: 2013
When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer

Author(s): Caldarella C | Treglia G | Giordano A | Giovanella L
Volume: 2013
Issue: default
Year: 2013
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management

Author(s): Leyva-Illades D | DeMorrow S
Volume: 2013
Issue: default
Year: 2013
Serous endometrial intraepithelial carcinoma: a case series and literature review

Author(s): Pathiraja P | Dhar S | Haldar K
Volume: 2013
Issue: default
Year: 2013
Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?

Author(s): Saif MW
Volume: 2013
Issue: default
Year: 2013
Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment

Author(s): Kaneda H | Yoshida T | Okamoto I
Volume: 2013
Issue: default
Year: 2013
Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer

Author(s): Tantraworasin A | Seateang S | Lertprasertsuke N | Arreyakajohn N | Kasemsarn C | Patumanond J
Volume: 2013
Issue: default
Year: 2013
Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery

Author(s): Sugimoto K | Shimizu N | Oki T | Nose K | Nishioka T | Adomi S | Ohzeki T | Esa A | Uemura H
Volume: 2013
Issue: default
Year: 2013
Advanced medullary thyroid cancer: pathophysiology and management

Author(s): Ferreira CV | Siqueira DR | Ceolin L | Maia AL
Volume: 2013
Issue: default
Year: 2013
Nedaplatin: a cisplatin derivative in cancer chemotherapy

Author(s): Shimada M | Itamochi H | Kigawa J
Volume: 2013
Issue: default
Year: 2013
Critical appraisal of the use of regorafenib in the management of colorectal cancer

Author(s): Festino L | Fabozzi A | Manzo A | Gambardella V | Martinelli E | Troiani T | De Vita F | Orditura M | Ciardiello F | Morgillo F
Volume: 2013
Issue: default
Year: 2013
Economic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece

Author(s): Fragoulakis V | Kastritis E | Psaltopoulou T | Maniadakis N
Volume: 2013
Issue: default
Year: 2013
Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?

Author(s): Lopez-Basave HN | Morales-Vasquez F | Ruiz-Molina JM | Namendys-Silva SA | Vela-Sarmiento I | Ruan JM | Padilla Rosciano AE | Calderillo-Ruiz G | Diaz-Romero C | Herrera-Gomez A | Meneses-Garcia AA
Volume: 2013
Issue: default
Year: 2013
Endoscopic endonasal approach for the treatment of a large clival giant cell tumor complicated by an intraoperative internal carotid artery rupture

Author(s): Iacoangeli M | Di Rienzo A | Re M | Alvaro L | Nocchi N | Gladi M | De Nicola M | Scerrati M
Volume: 2013
Issue: default
Year: 2013
Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer

Author(s): Broggini M | Garassino MC | Damia G
Volume: 2013
Issue: default
Year: 2013
Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

Author(s): Harrison MR | Wong TZ | Armstrong AJ | George DJ
Volume: 2013
Issue: default
Year: 2013
Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma

Author(s): Nojiri S | Kusakabe A | Fujiwara K | Shinkai N | Matsuura K | Iio E | Miyaki T | Nomura T | Sobue S | Sano H | Hasegawa I | Ohno T | Takahashi Y | Orito E | Joh T
Volume: 2012
Issue: default
Year: 2012
Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

Author(s): Chan DL | Morris DL | Rao A | Chua TC
Volume: 2012
Issue: default
Year: 2012
New drugs and combinations for the treatment of soft-tissue sarcoma: a review

Author(s): Somaiah N | von Mehren M
Volume: 2012
Issue: default
Year: 2012
Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells

Author(s): Thamilselvan V | Menon M | Thamilselvan S
Volume: 2012
Issue: default
Year: 2012
Breast imaging reports for malignant lesions: are we maintaining recommended BI-RADS® lexicon standards?

Author(s): Masroor I | Azeemuddin M | Sakhawat S | Beg M | Sohail S | Ahmed R | Ul-Haq I | Mehboob J
Volume: 2012
Issue: default
Year: 2012
Current treatment options for the management of esophageal cancer

Author(s): Mawhinney MR | Glasgow RE
Volume: 2012
Issue: default
Year: 2012
Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma

Author(s): Osorio M | Gracia E | Reigosa E | Hernandez J | de la Torre A | Saurez G | Perez K | Viada C | Cepeda M | Carr A | Ávila Y | Rodríguez M | Fernandez LE
Volume: 2012
Issue: default
Year: 2012
Autophagy as a target for cancer therapy: new developments

Author(s): Carew JS | Kelly KR | Nawrocki ST
Volume: 2012
Issue: default
Year: 2012
Pelvic exenteration for colorectal cancer: oncologic outcome in 59 patients at a single institution

Author(s): López-Basave HN | Morales-Vásquez F | Herrera-Gómez Á | Padilla Rosciano A | Meneses-Garcíá A | Ruiz-Molina JM
Volume: 2012
Issue: default
Year: 2012
The effect of CyberKnife therapy on pulmonary function tests used for treating non-small cell lung cancer: a retrospective, observational cohort pilot study

Author(s): Agarwal R | Saluja P | Pham A | Ledbetter K | Bains S | Varghese S | Clements J | Kim YH
Volume: 2012
Issue: default
Year: 2012
Patient perception of disease control and psychological distress

Author(s): Mazzotti E | Sebastiani C | Marchetti P
Volume: 2012
Issue: default
Year: 2012
Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part II: combination with external radiation improves survival

Author(s): Kushchayev SV | Sankar T | Eggink LL | Kushchayeva YS | Wiener PC | Hoober JK | Eschbacher J | Liu R | Shi FD | Abdelwahab MG | Scheck AC | Preul MC
Volume: 2012
Issue: default
Year: 2012
Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part 1: stimulatory effects on blood monocytes and monocyte-derived cells of the brain

Author(s): Kushchayev SV | Sankar T | Eggink LL | Kushchayeva YS | Wiener PC | Hoober JK | Eschbacher J | Liu R | Shi FD | Abdelwahab MG | Scheck AC | Preul MC
Volume: 2012
Issue: default
Year: 2012
Importance of antiresorptive therapies for patients with bone metastases from solid tumors

Author(s): Talreja DB
Volume: 2012
Issue: default
Year: 2012
Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma

Author(s): Fisher R | Larkin J
Volume: 2012
Issue: default
Year: 2012
Occupational exposure to wood dust and formaldehyde and risk of nasal, nasopharyngeal, and lung cancer among Finnish men

Author(s): Siew SS | Kauppinen T, Kyyrönen P | Heikkila P | Pukkala E
Volume: 2012
Issue: default
Year: 2012
Retinoids in the treatment of glioma: a new perspective

Author(s): Mawson AR
Volume: 2012
Issue: default
Year: 2012
Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors

Author(s): Yim K-L
Volume: 2012
Issue: default
Year: 2012
Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution

Author(s): Tuca A | Guell E | Martinez-Losada E | Codorniu N
Volume: 2012
Issue: default
Year: 2012
Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity

Author(s): Wojcinski S | Nuengsri S | Hillemanns P | Schmidt W | Deryal M | Ertan K | Degenhardt F
Volume: 2012
Issue: default
Year: 2012
Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer

Author(s): Aitini E | Rossi A | Morselli P | Vivorio B | Bruschi A | Bottura C | Colombo GL.
Volume: 2012
Issue: default
Year: 2012
Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experience

Author(s): Moslemi MK | Lotfi F | Tahvildar SA
Volume: 2011
Issue: default
Year: 2011
Comparison of the impact of radiotherapy and radiochemotherapy on the quality of life of 1-year survivors with cervical cancer

Author(s): Krikeli M | Ekonomopoulou MT | Tzitzikas I | Goutzioulis A | Mystakidou K | Pistevou-Gompaki K
Volume: 2011
Issue: default
Year: 2011
Use of neutral plasma coagulation in groin node dissection for vulvar malignancy: a novel technique

Author(s): Madhuri TK | Tailor A | Butler-Manuel S
Volume: 2011
Issue: default
Year: 2011
Latest developments and emerging treatment options in the management of stomach cancer

Author(s): Delaunoit T
Volume: 2011
Issue: default
Year: 2011
Factors influencing distant recurrence of hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization therapy in patients with hepatitis C

Author(s): Nojiri S | Kusakabe A | Shinkai N | Matsuura K | Iio E | Miyaki T | Joh T
Volume: 2011
Issue: default
Year: 2011
Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates?

Author(s): Dimitropoulos C | Hillas G | Nikolakopoulou S | Kostara K | Sagris K | Vlastos F | Alchanatis M
Volume: 2011
Issue: default
Year: 2011
Use of capecitabine in management of early colon cancer

Author(s): Hameed H | Cassidy J
Volume: 2011
Issue: default
Year: 2011
Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver

Author(s): Abedini F | Ismail M | Hosseinkhani H | Tengku Ibrahim TA | Omar AR | Chong PP | Hair Bejo M | Domb AJ
Volume: 2011
Issue: default
Year: 2011
Patient–provider communication data: linking process and outcomes in oncology care

Author(s): Kennedy Sheldon L | Hong F | Berry DL
Volume: 2011
Issue: default
Year: 2011
Erratum

Author(s): Krikeli M | Ekonomopoulou MT | Tzitzikas J | Goutzioulis A | Mystakidou K | Pistevou-Gompaki K
Volume: 2011
Issue: default
Year: 2011
C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map

Author(s): Kutikhin AG | Yuzhalin AE
Volume: 2012
Issue: default
Year: 2012
Psychological and sexual disorders in long-term breast cancer survivors

Author(s): Pumo V | Milone G | Iacono M | Rametta Giuliano S | Di Mari A | Lopiano C | Bordonaro S, Tralongo P
Volume: 2012
Issue: default
Year: 2012
Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy

Author(s): Roberts SM | Bezinover DS | Janicki PK
Volume: 2012
Issue: default
Year: 2012
Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis

Author(s): Richhariya A | Qian Y | Zhao Y | Chung K
Volume: 2012
Issue: default
Year: 2012
Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?

Author(s): Kutikhin AG | Yuzhalin AE
Volume: 2012
Issue: default
Year: 2012
Are Toll-like receptor gene polymorphisms associated with prostate cancer?

Author(s): Kutikhin AG | Yuzhalin AE
Volume: 2012
Issue: default
Year: 2012
Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia

Author(s): Molica S | Mirabelli R | Molica M, Levato L | Mauro F | Foà R
Volume: 2011
Issue: default
Year: 2011
Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort

Author(s): Crawford ED | Phillips JM
Volume: 2011
Issue: default
Year: 2011
Deciding what information is necessary: do patients with advanced cancer want to know all the details?

Author(s): Russell BJ | Ward AM
Volume: 2011
Issue: default
Year: 2011
Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics

Author(s): Wacheck V | Lahn M | Dickinson G | Füreder W | Meyer R | Herndlhofer S | Füreder T | Dorfner G | Pillay S | André V | Burkholder TP | Akunda JK | Flye-Blakemore L | Van Bockstaele D | Schlenk RF | Sperr W | Valent P
Volume: 2011
Issue: default
Year: 2011
Improving evaluation of the distribution and density of immunostained cells in breast cancer using computerized video image analysis

Author(s): Coventry BJ | Weightman MJ | Skinner JM | Bradley J
Volume: 2011
Issue: default
Year: 2011
Chemoprevention of prostate cancer with nutrients and supplements

Author(s): Van Poppel H | Tombal B
Volume: 2011
Issue: default
Year: 2011
Capecitabine in the management of colorectal cancer

Author(s): Hirsch BR | Zafar SY
Volume: 2011
Issue: default
Year: 2011
Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia

Author(s): David L DeRemer | Katerina Katsanevas | Celalettin Ustun
Volume: 2011
Issue: default
Year: 2011
Critical appraisal of trastuzumab in treatment of advanced stomach cancer

Author(s): Judith Meza-Junco | Heather-Jane Au | Michael B Sawyer
Volume: 2011
Issue: default
Year: 2011
Kefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytes

Author(s): Katia Maalouf | Elias Baydoun | Sandra Rizk
Volume: 2011
Issue: default
Year: 2011
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy

Author(s): Rudolph M Navari
Volume: 2009
Issue: default
Year: 2009
The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma

Author(s): Ibrahim T Aldoss | Susan M Blumel | Philip J Bierman
Volume: 2009
Issue: default
Year: 2009
Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations

Author(s): Margarita García | Ana Clopés | Jordi Bruna
Volume: 2009
Issue: default
Year: 2009
Update on the management of prostate cancer with goserelin acetate: patient perspectives

Author(s): Shandra Wilson
Volume: 2009
Issue: default
Year: 2009
Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron

Author(s): Emilio Bajetta | Sara Pusceddu | Valentina Guadalupi | et al
Volume: 2009
Issue: default
Year: 2009
Evolving role of cetuximab in the treatment of colorectal cancer

Author(s): Gunter Schuch | Sebastian Kobold | Carsten Bokemeyer
Volume: 2009
Issue: default
Year: 2009
Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer

Author(s): Marta Vallee Cobham | Diana Donovan
Volume: 2009
Issue: default
Year: 2009
Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222

Author(s): Aminah Jatoi | Shauna L Hillman | Katie L Allen Ziegler | Philip J Stella | et al.
Volume: 2009
Issue: default
Year: 2009
Patient-derived acute myeloid leukemia (AML) bone marrow cells display distinct intracellular kinase phosphorylation patterns

Author(s): Keith Shults | Leanne Flye | Lisa Green | Thomas Daly | et al.
Volume: 2009
Issue: default
Year: 2009
Validation of the cell cycle G2 delay assay in assessing ionizing radiation sensitivity and breast cancer risk

Author(s): Jeff W Hill | Kristina Tansavatdi | Kristin L Lockett | Glenn O Allen | et al.
Volume: 2009
Issue: default
Year: 2009
Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer

Author(s): Anthony V Nguyen | Micaela Martinez | Michael J Stamos | Mary P Moyer | Kestutis Planutis | Christopher Hope | Randall F Holcombe
Volume: 2009
Issue: default
Year: 2009
TGFβ signaling supports survival and metastasis of endometrial cancer cells

Author(s): XiuFen Lei | Long Wang | Junhua Yang | Lu-Zhe Sun
Volume: 2009
Issue: default
Year: 2009
Computer-aided detection of colonic polyps with level set-based adaptive convolution in volumetric mucosa to advance CT colonography toward a screening modality

Author(s): Hongbin Zhu | Chaijie Duan | Perry Pickhardt | Su Wang | et al.
Volume: 2009
Issue: default
Year: 2009
Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients

Author(s): Henry G Kaplan | Judith A Malmgren | Mary Atwood | et al
Volume: 2010
Issue: default
Year: 2010
Treatment of cutaneous melanoma: current approaches and future prospects

Author(s): Alain P Algazi | Christopher W Soon | Adil I Daud
Volume: 2010
Issue: default
Year: 2010
Efficacy and safety of amrubicin hydrochloride for treatment of relapsed small cell lung cancer

Author(s): Daiki Ogawara | Minoru Fukuda | Yoichi Nakamura | et al
Volume: 2010
Issue: default
Year: 2010
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms

Author(s): Joseph Tripodi | Ronald Hoffman | Vesna Najfeld | et al
Volume: 2010
Issue: default
Year: 2010
Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art

Author(s): Piotr Milecki | Piotr Martenka | Andrzej Antczak | et al
Volume: 2010
Issue: default
Year: 2010
New developments in treatment of ovarian carcinoma: focus on trabectedin

Author(s): Philippe A Cassier | Aude Duret | Olivier Trédan | et al
Volume: 2010
Issue: default
Year: 2010
Role of intranasal fentanyl in breakthrough pain management in cancer patients

Author(s): Wojciech Leppert
Volume: 2010
Issue: default
Year: 2010
Review of catumaxomab in the treatment of malignant ascites

Author(s): Martin Sebastian
Volume: 2010
Issue: default
Year: 2010
The potential carcinogenic risk of tanning beds: clinical guidelines and patient safety advice

Author(s): Mette Mogensen | Gregor BE Jemec
Volume: 2010
Issue: default
Year: 2010
FACE: the barefaced facts of AI potency

Author(s): Alain Monnier
Volume: 2010
Issue: default
Year: 2010
Cancer chemotherapy: targeting folic acid synthesis

Author(s): Nicole Hagner | Markus Joerger
Volume: 2010
Issue: default
Year: 2010
The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients

Author(s): Georgios Hillas | Petros Bakakos | Miltiadis Trichas | et al
Volume: 2010
Issue: default
Year: 2010
Colonic polyps: inheritance, susceptibility, risk evaluation, and diagnostic management

Author(s): Emanuele Neri | Lorenzo Faggioni | Lorenzo Cini | et al
Volume: 2011
Issue: default
Year: 2010
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies

Author(s): Tawara K | Oxford JT | Jorcyk C
Volume: 2011
Issue: default
Year: 2011
Optimal management of cancer anorexia–cachexia syndrome

Author(s): Josep M Argilés | Mireia Olivan | Sílvia Busquets | et al
Volume: 2010
Issue: default
Year: 2010
Rituximab for the treatment of patients with chronic lymphocytic leukemia

Author(s): M Gentile | E Vigna | C Mazzone | et al
Volume: 2010
Issue: default
Year: 2010
Everolimus – a new approach in the treatment of renal cell carcinoma

Author(s): G Anandappa | AE Hollingdale | TG Eisen
Volume: 2010
Issue: default
Year: 2010
Role of bevacizumab therapy in the management of glioblastoma

Author(s): Scott J Peak | Victor A Levin
Volume: 2010
Issue: default
Year: 2010
A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults

Author(s): Paul J Novotny | Denise J Smith | Lorna Guse | et al
Volume: 2010
Issue: default
Year: 2010
Management of metastatic renal cell carcinoma in patients with poor prognosis

Author(s): Andrea Bullock | David F McDermott | Michael B Atkins
Volume: 2010
Issue: default
Year: 2010
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit

Author(s): Paul G Corn | Timothy C Thompson
Volume: 2010
Issue: default
Year: 2010
Global cancer research initiative

Author(s): Richard R Love
Volume: 2010
Issue: default
Year: 2010
Ixabepilone development across the breast cancer continuum: a paradigm shift

Author(s): Nuhad K Ibrahim
Volume: 2010
Issue: default
Year: 2010
Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

Author(s): Didier Dequanter | Mohammad Shahla | Pascal Paulus | et al
Volume: 2010
Issue: default
Year: 2010
Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma

Author(s): S Galimberti | M Petrini
Volume: 2010
Issue: default
Year: 2010
Cancer prevention, aerobic capacity, and physical functioning in survivors related to physical activity: a recent review

Author(s): Matthew S Wiggins | Emily M Simonavice
Volume: 2010
Issue: default
Year: 2010
From antiangiogenesis to hypoxia: current research and future directions

Author(s): Christopher Rice | L Eric Huang
Volume: 2011
Issue: default
Year: 2010
Reduced cancer risk in vegetarians: an analysis of recent reports

Author(s): Amy Joy Lanou | Barbara Svenson
Volume: 2011
Issue: default
Year: 2010
The role of azacitidine in the management of myelodysplastic syndromes (MDS)

Author(s): KS Götze | C Müller-Thomas | C Peschel
Volume: 2009
Issue: default
Year: 2009
Bortezomib in the management of multiple myeloma

Author(s): Jacob P Laubach | Constantine S Mitsiades | Teru Hideshima | et al
Volume: 2009
Issue: default
Year: 2009
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma

Author(s): Frederick Lansigan | Diane M Stearns | Francine Foss
Volume: 2010
Issue: default
Year: 2010
Evaluation of degarelix in the management of prostate cancer

Author(s): Hendrik Van Poppel
Volume: 2010
Issue: default
Year: 2010
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer

Author(s): Catherine Oakman | Marta Pestrin | Elena Zafarana | et al
Volume: 2010
Issue: default
Year: 2010
Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab

Author(s): Ronald M Bukowski
Volume: 2010
Issue: default
Year: 2010
Epigenomics in cancer management

Author(s): Fabricio F Costa
Volume: 2010
Issue: default
Year: 2010
Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies

Author(s): Gina M Mantia-Smaldone | Robert P Edwards | Anda M Vlad
Volume: 2011
Issue: default
Year: 2010
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

Author(s): Noemí Reguart | Andrés Felipe Cardona | Rafael Rosell
Volume: 2010
Issue: default
Year: 2010
Affiliate Program      Why do you need a reservation system?